Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06106269 · ClinicalTrials.gov registry record
Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids
A clinical trial of Internal Hemorrhoid, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT06106269 is a study of Internal Hemorrhoid that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06106269, a study of Internal Hemorrhoid, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess how effective and safe rectal artery embolization works to treat symptomatic bleeding predominant internal hemorrhoids.
Conditions Studied
Interventions
- DEVICE Rectal Artery Embolization
Study Locations (1)
Minnesota
- Mayo Clinic Minnesota - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-06-07 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06106269
The ClinicalTrials.gov registry entry for NCT06106269 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Internal Hemorrhoid appearing as the primary indexed condition, and to 1 intervention - of which Rectal Artery Embolization is the first listed.
NCT06106269 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06106269 about?
NCT06106269 is a clinical study titled "Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids". This study will assess how effective and safe rectal artery embolization works to treat symptomatic bleeding predominant internal hemorrhoids.
What is the current status of trial NCT06106269?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2024-06-07. Estimated completion is 2026-12.
What conditions does trial NCT06106269 study?
This clinical trial studies the following conditions: Internal Hemorrhoid.
What interventions are being tested in trial NCT06106269?
The interventions under investigation include: Rectal Artery Embolization (DEVICE).
Who is sponsoring clinical trial NCT06106269?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06106269 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.